Eli Lilly
LLY
1,368 hedge funds and large institutions have $71.2B invested in Eli Lilly in 2018 Q2 according to their latest regulatory filings, with 121 funds opening new positions, 426 increasing their positions, 544 reducing their positions, and 78 closing their positions.
55% more first-time investments, than exits
New positions opened: 121 | Existing positions closed: 78
10% more capital invested
Capital invested by funds: $64.7B → $71.2B (+$6.48B)
5% more funds holding in top 10
Funds holding in top 10: 22 → 23 (+1)
3% more funds holding
Funds holding: 1,334 → 1,368 (+34)
0.35% more ownership
Funds ownership: 76.56% → 76.91% (+0.35%)
6% less call options, than puts
Call options by funds: $368M | Put options by funds: $392M
22% less repeat investments, than reductions
Existing positions increased: 426 | Existing positions reduced: 544
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dodge & Cox
San Francisco,
California
|
+$425M |
| 2 |
JP Morgan Chase
New York
|
+$282M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$101M |
| 4 |
Morgan Stanley
New York
|
+$101M |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$88.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$268M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$250M |
| 3 |
Goldman Sachs
New York
|
-$137M |
| 4 |
Two Sigma Investments
New York
|
-$103M |
| 5 |
LCOV
London Company of Virginia
Richmond,
Virginia
|
-$96.6M |
LLY Hedge Fund Activity: Q2 2018 in Review
1,368 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q2 2018, worth a combined $71.2B — up 10% from $64.7B a quarter earlier.
Buyers outnumbered sellers: 121 funds opened new LLY positions and 78 closed out — a net gain of 43 holders — while 426 added to existing stakes and 544 trimmed.
The largest buyer was Dodge & Cox, adding an estimated $425M. The largest seller was Renaissance Technologies, cutting an estimated $268M.
- 1,368 institutional investors held Eli Lilly (LLY) as of Q2 2018, up from 1,334 in Q1 2018.
- Funds reported $71.2B of Eli Lilly stock for Q2 2018, up 10% quarter-over-quarter.
- 121 funds opened new Eli Lilly positions in Q2 2018 and 78 closed out, a net change of +43 holders.
- The largest Eli Lilly buyer in Q2 2018 was Dodge & Cox, an estimated $425M added.
- The largest Eli Lilly seller in Q2 2018 was Renaissance Technologies, an estimated $268M sold.
Based on aggregated 13F filings for Q2 2018.